News
LGND
126.92
+4.29%
5.22
Weekly Report: what happened at LGND last week (0707-0711)?
Weekly Report · 19h ago
Director John W. Kozarich Reports Disposal of Common Shares in Ligand Pharmaceuticals Inc
Reuters · 3d ago
Ligand Pharma (LGND) Gets a Buy from Craig-Hallum
TipRanks · 3d ago
Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease
Benzinga · 4d ago
Ligand Pharm's Partner Pelthos Therapeutics Commercially Launches ZELSUVMI Topical Gel 10.3%, FDA-Approved At-Home Treatment For Molluscum Contagiosum
Benzinga · 4d ago
LIGAND PHARMACEUTICALS INC - EARNS $5 MLN MILESTONE PAYMENT FROM PELTHOS FOLLOWING COMMERCIAL LAUNCH OF ZELSUVMI
Reuters · 4d ago
LIGAND PARTNER PELTHOS THERAPEUTICS LAUNCHES ZELSUVMI™
Reuters · 4d ago
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
Benzinga · 5d ago
Reported July 3, 2025: Pelthos Therapeutics 13D Filing Shows Ligand Pharmaceuticals Discloses 49.9% Stake As Of July 1, 2025
Benzinga · 07/07 15:06
Weekly Report: what happened at LGND last week (0630-0704)?
Weekly Report · 07/07 11:52
Ligand Pharma (LGND) Gets a Buy from Craig-Hallum
TipRanks · 07/02 13:15
Ligand, Pelthos Close Merger Deal With Channel's CHRO; To Launch ZELSUVMI In July
NASDAQ · 07/02 11:56
Ligand Pharma Completes Merger Forming Pelthos Therapeutics
TipRanks · 07/02 11:27
Pelthos Therapeutics completes merger with Channel Therapeutics
TipRanks · 07/02 11:05
*Ligand Pharma: Concurrent With Merger, Pelthos Raised $50.1M of Equity Cap, Including Private Placement From Group of Investors Led by Murchinson >LGND
Dow Jones · 07/02 11:04
*Ligand Pharma: Investor Group Invested $32M, Ligand Invested $18M in Combined Co >LGND
Dow Jones · 07/02 11:04
Press Release: Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
Dow Jones · 07/02 11:01
PELTHOS THERAPEUTICS INC- PELTOS TO TRADE ON NYSE AMERICAN AS 'PTHS' STARTING JULY 2, 2025
Reuters · 07/02 11:00
LIGAND ANNOUNCES COMPLETION OF PELTHOS THERAPEUTICS MERGER WITH CHANNEL THERAPEUTICS
Reuters · 07/02 11:00
Weekly Report: what happened at LGND last week (0623-0627)?
Weekly Report · 06/30 12:01
More
Webull provides a variety of real-time LGND stock news. You can receive the latest news about Ligand Pharma through multiple platforms. This information may help you make smarter investment decisions.
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.